We are so pleased to have developed a new content series we’re calling “Bullish vs Bearish.”

The Concept? We’ll lay out a company, premise, or any other asset in the psychedelics industry, and our host, Adam Tubero, will weigh in with his sentiment.

The result should be informative deep-downs into some of the most important things that are happening to move the markets. Adam will dig in, provide observations, and informally respond with a “bullish” or “bearish” reaction.

The Debut Episode

In the first episode of Bullish vs Bearish, Adam shares his feelings regarding Cybin‘s (CYBN) fiscal year 2022 financial results and pipeline highlights. Has Adam maintained his bullish outlook on Cybin after breaking down the company’s most recent earnings report? Tune in and find out.